Article | February 4, 2026

NovaPure® Syringe Plungers eBook: Chapter 4: Drug Product Compatibility

West-88_NovaPureSyringes_0929

Maintaining the sterility and stability of injectable drug products is a critical challenge, especially as regulatory standards like EU GMP Annex 1 intensify. Throughout a syringe system’s lifecycle, environmental factors and component interactions constantly threaten drug integrity. For sensitive biologic molecules and viral vectors, the risk extends beyond simple contamination; contact with incompatible packaging materials can lead to protein adsorption, reduced dosage accuracy, and impaired long-term stability.

To mitigate these risks, advanced barrier technologies—such as ETFE-based films—are employed on plunger drug-contact surfaces. These films lower surface energy, creating a chemically inert boundary that prevents the migration of compounds from the elastomer into the formulation. Comparative analysis via headspace gas chromatography confirms that these barriers effectively separate the drug from the plunger, ensuring product efficacy and patient safety. Understanding these material interactions is essential for navigating modern containment challenges.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

West Pharmaceutical Services, Inc.